VCM
RMD icon

Voleon Capital Management’s ResMed RMD Stock Holding History

Voleon Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$471K Buy
2,100
+278
+15% +$69.3K 0.01% 587
2025
Q4 		$439K Sell
1,822
-205
-10% -$52.4K 0.01% 604
2025
Q3 		$555K Buy
2,027
+896
+79% +$245K 0.01% 552
2025
Q2 		$292K Buy
+1,131
New +$270K 0.02% 407

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Voleon Capital Management's RMD Position: Q1 2026 in Review

Voleon Capital Management increased its ResMed (RMD) stake by 15% in Q1 2026, buying an estimated $69.3K and bringing the position to 2,100 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #587.

Voleon Capital Management first reported a position in RMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $555K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Voleon Capital Management held 2,100 shares of ResMed worth $471K as of Q1 2026.
  • Voleon Capital Management bought 278 ResMed shares in Q1 2026, an estimated $69.3K.
  • ResMed made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #587 holding.
  • Voleon Capital Management first reported a position in ResMed in Q2 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's ResMed position peaked at $555K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.